Suppr超能文献

[肝素与一种极低分子量肝素在慢性肾功能不全血液透析中的对比研究]

[Comparative study of heparin and a very low molecular-weight heparin in hemodialysis in chronic renal insufficiency].

作者信息

Hory B, Cachoux A, Saunier F, Kieffer Y, Laroze M, Henriet M T, Toulemonde F, Bayrou B, Perol C

出版信息

Presse Med. 1987 May 23;16(19):955-8.

PMID:2954145
Abstract

In the course of dialysis sessions, we have compared the antithrombotic effect of two heparinization regimens: low molecular weight heparin (CY 222, mean molecular weight: 2,500, Institute Choay, France): 90 anti-Xa units/kg bodyweight as a bolus injection followed by a continuous infusion of 1,000 anti-Xa units/hour (regimen 1); or 300 anti-Xa units/kg as a bolus injection (regimen 3), with a standard heparinization regimen (100 IU/kg regimen 2). Eight patients received the 3 regimens successively. Factor IIa and factor Xa inactivation was measured by a method that uses chromogenic substrates. The frequency of adverse effects, ultrafiltration rates, creatinine and BUN clearances of the 3 regimens were similar, whereas dialyser blood loss was higher in the first regimen. At the dose of 300 anti-Xa units of CY 222 (regimen 3), inactivation of factor Xa was similar to Xa inhibition reached through the conventional treatment (regimen 2) but IIa inhibition was less pronounced.

摘要

在透析过程中,我们比较了两种肝素化方案的抗血栓形成效果:低分子量肝素(CY 222,平均分子量:2500,法国乔雅研究所):90抗Xa单位/千克体重静脉推注,随后以1000抗Xa单位/小时持续输注(方案1);或300抗Xa单位/千克静脉推注(方案3),与标准肝素化方案(100 IU/千克,方案2)进行比较。8名患者先后接受了这3种方案。采用使用显色底物的方法测定IIa因子和Xa因子的失活情况。3种方案的不良反应发生率、超滤率、肌酐清除率和尿素氮清除率相似,而第一种方案的透析器失血较多。在CY 222剂量为300抗Xa单位时(方案3),Xa因子的失活与传统治疗(方案2)达到的Xa抑制效果相似,但IIa抑制作用不那么明显。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验